Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for oral delivery of proteins

A protein and matrix technology, applied in the field of oral release of protein, can solve the problem of lack of available release carriers

Inactive Publication Date: 2000-07-05
PURDUE RES FOUND INC
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, currently there is a lack of effective delivery vehicles available

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for oral delivery of proteins
  • Method for oral delivery of proteins
  • Method for oral delivery of proteins

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] pH-dependent release of P(MAA-g-EG) hydrogel contents

[0043] The ability of P(MAA-g-EG) hydrogels to serve as release vehicles for three compounds of different sizes: theophylline (MW 180.2), vancomycin (MW 1485.7) and insulin (MW 5733.2) was investigated.

[0044] P(MAA-g-EG) hydrogels were prepared by radical solution polymerization of methacrylic acid and poly(ethylene glycol) monomethacrylate at 37 °C, and the resulting oligomer chains were combined with dimethylmethacrylate Tetraglycerides cross-linked. The resulting hydrogel was rinsed in deionized water for one week to remove unreacted monomers and un-crosslinked oligomer chains, vacuum dried and ground into a powder with an average particle diameter of 100-150 μm.

[0045]Drug incorporation experiments were performed using theophylline (MW 180.2), vancomycin (MW 1485.7) and insulin (MW 5733.2). Each drug was dissolved in pH 7.4 phosphate buffer and P(MAA-g-EG) hydrogel was added to the drug solution to load ...

Embodiment 2

[0049] In vitro mucoadhesion studies

[0050] P(MAA-g-EG) hydrogels were fabricated into thin films using solution polymerization technique. The hydrogels were swollen and equilibrated in DMGA buffered saline at pH = 3.2 and 7.4. The swelled hydrogel was cut into disks with a diameter of 20 cm and placed in a tensile tester at 25°C and 90% RH. Whereas the gelled bovine submandibular mucin sample was fixed in the lower port with adhesive, the polymer sample was adhered to the upper handle of the detector using cyanoacrylate medical adhesive. The two mouths were pulled together for 15 minutes and then separated at a speed of 1 mm / min. The separation force was measured as a function of displacement. Work of separation, equal to the work of bioadhesion calculated by the area under the curve.

[0051] Since P(MAA-g-EG) hydrogel can block the effect of protease inhibitors, and can be attached to the intestinal wall mucosa, making close contact and thus facilitating the absorptio...

Embodiment 3

[0058] In Vivo Study of Insulin Administration in Rats

[0059] Graft copolymers were prepared by free-radical solution polymerization of methacrylic acid and poly(ethylene glycol) monomethacrylate. The resulting hydrogel was rinsed in deionized water for 7 days to remove unreacted monomer and un-crosslinked oligomer chains, and the hydrogel was vacuum dried and ground into a powder. The powder is filtered to obtain granules with an average particle diameter of 100-150 μm. Crystalline porcine insulin (26.9 U / mg) was loaded by balanced distribution. The drug-loaded particles were filtered and washed to remove surface drug and vacuum dried.

[0060] Male Wistar rats (200 g) were fasted for 24 hours. Rats were fixed in the supine position, and insulin-loaded polymer gelatin capsule microparticles were administered, and the gelatin capsules dissolved immediately in the stomach. Blood samples were collected from the jugular vein in 0.2 ml aliquots for serum glucose before the e...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Diameteraaaaaaaaaa
Login to View More

Abstract

A composition and method are described for the oral administration of bioactive components to vertebrates. The method comprises the step of orally administering the vertebrate a composition comprising a swellable hydrogel matrix and a bioactive composition contained within the hydrogel matrix.

Description

field of invention [0001] The present invention relates to a composition comprising a swellable hydrogel matrix and a protein contained in the matrix, and the use of the composition for oral delivery of a biologically active compound in active form into the vertebrate intestine. Background of the invention [0002] There are two main problems in the development of oral delivery systems for proteinaceous compounds such as insulin. The first problem is that many proteins are inactivated by digestive enzymes in the gastrointestinal (GI) system, mainly the stomach. This problem can be overcome by designing a carrier that protects the protein from the harsh environment of the stomach before releasing the drug into more favorable regions of the GI tract, especially the lower gut. In addition, protease inhibitors can be used to block the activity of enzymes present in the GI system that break down orally administered proteins. Another problem is the slow transport of intact large...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/00A61K9/16A61K9/48G06Q50/00A61K38/28A61K47/32
CPCA61K38/28A61K9/1635A61K9/48
Inventor N·A·佩帕斯A·M·洛曼T·纳盖M·莫里施塔
Owner PURDUE RES FOUND INC